We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Shocking Heart in Cardiac Arrest May Be Harmful

By HospiMedica staff writers
Posted on 23 Oct 2002
An animal study has found that shocking the heart 10 minutes after cardiac arrest probably will not help and may be detrimental. More...
The study was reported at the American College of Emergency Physicians Scientific Assembly 2002 in Seattle (WA, USA).

Researchers used two clinical scenarios for sudden cardiac arrest in real-time by waiting between eight to 10 minutes and 10-12 minutes from the onset to begin resuscitation efforts. This is about the amount of time it takes for first responders to arrive at the scene of a patient in cardiac arrest. The subjects were treated with one of three strategies: immediate defibrillation, a combination of cardiopulmonary resuscitation (CPR) then intravenous drugs followed by defibrillation, or intravenous drugs and CPR simultaneously before defibrillation. The researchers found that immediate defibrillation was least effective and there was a significant delay in restoring circulation. There were no significant differences in subjects resuscitated at eight to 10 minutes or at 10-12 minutes.

"Although rapid defibrillation is hands down the best method to resuscitate victims minutes after sudden cardiac arrest, we now have additional evidence that indicates the longer someone is in prolonged cardiac arrest, providing immediate defibrillation is not the most effective way to resuscitate because the injured heart is only further damaged by shocking it,” said James Menegazzi, Ph.D., lead author and research professor of emergency medicine at the University of Pittsburgh School of Medicine (PA, USA).




Related Links:
Univ. Pittsburgh

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.